Start with its own history
At 18.59×, RPHCF is 20.5% below its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

Current valuation, historical context, and peer comparisons.
Current P/E ratio
18.59×
20.5% belowthe 10-year annual average
Price and EPS in quote currency. Calculation details
Investors are paying 18.59 for every 1 of reported earnings per share.
Annual period-end data · 17 observations
| Period end | P/E | Change |
|---|---|---|
| Mar 31, 2026 | 15.88× | -3.3% |
| Mar 31, 2025 | 16.43× | -25.8% |
| Mar 31, 2024 | 22.15× | -7.5% |
| Mar 31, 2023 | 23.96× | +20.1% |
| Mar 31, 2022 | 19.95× | -0.8% |
| Mar 31, 2021 | 20.12× | -8.2% |
| Mar 31, 2020 | 21.91× | -34.1% |
| Mar 31, 2019 | 33.22× | -8.9% |
| Period end | P/E | Change |
|---|---|---|
| Mar 31, 2018 | 36.49× | +53.8% |
| Mar 31, 2017 | 23.72× | -7.4% |
| Mar 31, 2016 | 25.61× | +14.1% |
| Mar 31, 2015 | 22.46× | -4.9% |
| Mar 31, 2014 | 23.61× | +30.6% |
| Mar 31, 2013 | 18.09× | +21.6% |
| Mar 31, 2012 | 14.87× | +13.7% |
| Mar 31, 2011 | 13.08× | -16.1% |
| Mar 31, 2010 | 15.59× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
RPHCF This stockRohto Pharmaceutical Co.,Ltd. | 18.59× |
4967.TKobayashi Pharmaceutical Co., Ltd. | 111.24× |
4911.TShiseido Company, Limited | 34.68× |
4922.TKOSE Holdings Corporation | 26.33× |
4912.TLion Corporation | 25.27× |
4452.TKao Corporation | 25.61× |
4985.TEarth Corporation | 28.66× |
2267.TYakult Honsha Co.,Ltd. | 18.78× |
4516.TNippon Shinyaku Co., Ltd. | 7.56× |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
At 18.59×, RPHCF is 20.5% below its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
The median of the 8 positive peer ratios above is 25.97×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore Wisesheets=WISE("RPHCF", "PE Ratio", "LQ")Share price 17.1959 ÷ EPS 0.9249 = 18.59×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 22, 2026; this is not a real-time trading quote.
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
The essentials behind the numbers.